lead by example, overcome difficulties, open up and innovate
Release time:
2022-03-22
Looking back on the years of working in the municipal pharmaceutical company, my achievements cannot be separated from the training and support of the leaders of the group and the pharmaceutical industry, and cannot be separated from the strong support and cooperation of all colleagues. In recent years, municipal pharmaceutical companies have faced unfavorable factors of national policies and a fiercely competitive market, especially with the full implementation of the two-invoice system for drug sales in public hospitals and the rapid advancement of national and local centralized procurement, drug profit margins have been compressed., The distribution of drugs has been in a state of meager profit. In order to optimize personnel and save sales costs, drug sales channels have also become centralized, and drug distribution has been concentrated on commercial distribution companies covering the whole province. The city's pharmaceutical companies are facing competition from Zhejiang provincial-level commercial enterprises in terms of low prices, concessions, market grabbing and homogenization. As the person in charge of an enterprise, I have the responsibility to work with the team to lead a company with more than 100 employees and a history of 70 to overcome difficulties.
After careful market analysis, since the distribution of two-ticket products cannot compete with the distribution enterprises covered by the whole province, our way out lies in the distribution of non-two-ticket products. The goal is clear. On the one hand, we use the group's financial advantages to ensure the sales of existing products by improving services. On the other hand, we have targeted to expand the sales of non-two-vote products, especially special drugs, narcotic drugs, psychotropic drugs and Chinese herbal medicine decoction pieces, as well as OTC products. In addition, we have won their support through frequent market operation and repeated communication with relevant government departments, so that the pharmaceutical company continues to be the only municipal enterprise with special drug distribution qualification in Jinhua City, forming an effective industry barrier. At the same time, we have strengthened close contact with special drug suppliers, made every effort to provide good services, and actively cooperated with them in price maintenance, which not only ensured the interests of suppliers but also ensured the reasonable profits of our company. As the distribution profit margin of special drugs is much higher than that of ordinary drugs, the sharp increase in sales effectively makes up for the decline in sales of two-vote products.
While doing a good job in the sales increase of special drugs, we have vigorously expanded the sales of Chinese herbal pieces and improved our business with Tianshili Group. In 2021 , Health Technology Company processed Chinese herbal pieces to 1100 , bringing the sales of Chinese herbal pieces to a new level. In terms of increasing the sales of OTC , we have introduced the general distributors of well-known brands such as Donge Ejiao and Nanjing Tongrentang in Jinhua area, which not only expanded the sales, but also enhanced the company's influence in Jinhua area.
In order to seek the development of the company, the group purchased a plot of land in Jinxing South Street in the urban area to serve as a reserve for the relocation of the Huancheng East Road warehouse, which did not produce benefits. Through proper renovation, we have successfully hired more than 4 million rents since 2018 . 2021 At the beginning of the year, the plot was included in the government purchasing and storage plan of Jinhua Economic Development Zone. In order to obtain more land compensation, we have taken the initiative to connect with government departments such as development zones, natural resources and planning bureaus for many times, and at the same time compare the compensation levels of other depositors horizontally. Through efforts to coordinate and strive for it, we should also thank the general manager of the pharmaceutical industry for his strong support and realize the maximization of land compensation.
As secretary of the general party branch of the municipal pharmaceutical company, I set an example and distinguish between public and private. Insist on demanding yourself with high standards, take the lead in problems and face up to difficulties. All our party members can also play an exemplary role, making party members the backbone of the company. The general party branch of the pharmaceutical company has also won the title of "Advanced Party Organization " for many years. Under the vanguard and exemplary role of all party members, the cohesion of all employees has been greatly improved, which provides a strong guarantee for the sustainable and stable development of pharmaceutical companies.
In the new year, although the situation in the pharmaceutical industry is more severe, I will live up to my trust and lead all employees to overcome difficulties, pioneer and innovate, and strive for new victories. (According to Wu Weisheng's speech at the summary and commendation meeting of the pharmaceutical company)
More information
Company fully deploys 2019 work
On January 28, the group company held a business analysis meeting to review and summarize the work situation in 2018, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises made reports on the overall work situation in 2018, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2019. Xiang Chongping, deputy general manager of the group company, made a systematic review of the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the internal control, safety and environmental protection work in 2018. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2018 and made a comparative analysis of the main economic indicators of each industrial sector. In 2018, the operating indicators of the company's various industrial sectors have improved significantly year-on-year, and the group company has also created the best operating performance in history. All units have completed the formulation of the second round of "three-year business plan", which points out the direction for the next three years of business work; the group company has also completed the first draft of the new "five-year strategic development plan", which is being revised and enriched. In addition, the two main businesses have also made substantial progress in investment expansion and industrial integration around strategic objectives, and the operating costs of major enterprises have decreased to varying degrees; the optimization of organizational structure and post setting has achieved new results, and management efficiency and people
2020
07-22
Company fully deploys 2019 work
On January 28, the group company held a business analysis meeting to review and summarize the work situation in 2018, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises made reports on the overall work situation in 2018, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2019. Xiang Chongping, deputy general manager of the group company, made a systematic review of the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the internal control, safety and environmental protection work in 2018. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2018 and made a comparative analysis of the main economic indicators of each industrial sector. In 2018, the operating indicators of the company's various industrial sectors have improved significantly year-on-year, and the group company has also created the best operating performance in history. All units have completed the formulation of the second round of "three-year business plan", which points out the direction for the next three years of business work; the group company has also completed the first draft of the new "five-year strategic development plan", which is being revised and enriched. In addition, the two main businesses have also made substantial progress in investment expansion and industrial integration around strategic objectives, and the operating costs of major enterprises have decreased to varying degrees; the optimization of organizational structure and post setting has achieved new results, and management efficiency and people
2020
07-31
The truth about private equity investments you need to know.
China Securities Regulatory Commission Zhejiang Regulatory Bureau and China Securities Investor Protection Fund Co., Ltd. jointly launched the "those private equity fund investment truth you need to know" investment education products. With the outbreak of private equity investment, the proportion of individual investors has further increased, and there are more and more "rich myth" scams. But the things behind "private placement" may not be as simple as you think, and risk prevention knowledge needs to be known early.
2020
07-31
The truth about private equity investments you need to know.
China Securities Regulatory Commission Zhejiang Regulatory Bureau and China Securities Investor Protection Fund Co., Ltd. jointly launched the "those private equity fund investment truth you need to know" investment education products. With the outbreak of private equity investment, the proportion of individual investors has further increased, and there are more and more "rich myth" scams. But the things behind "private placement" may not be as simple as you think, and risk prevention knowledge needs to be known early.
2020
07-30
The truth about private equity investments you need to know.
China Securities Regulatory Commission Zhejiang Regulatory Bureau and China Securities Investor Protection Fund Co., Ltd. jointly launched the "those private equity fund investment truth you need to know" investment education products. With the outbreak of private equity investment, the proportion of individual investors has further increased, and there are more and more "rich myth" scams. But the things behind "private placement" may not be as simple as you think, and risk prevention knowledge needs to be known early.
2020
07-31
Chairman Jiang Xiaomeng Directs Work in Yunnan Peak
On December 16, Jiang Xiaomeng, Secretary of the Party committee and chairman of the group company, went to Yunnan Jianfeng cement company to investigate and guide the work. On the morning of the same day, accompanied by the Yunnan peak management team, Jiang Xiaomeng went deep into the front line and successively went to the central control room of the production and manufacturing department, the raw material clay yard, the lignite yard and other areas for field investigation and investigation to understand the problems existing in the production and operation process. Subsequently, a business analysis meeting was held to make a comparative analysis of the various business indicators of Yunnan Jianfeng from January to November this year, and put forward two requirements to the management team: further strengthen internal management and improve execution; strengthen the coordination of external relations, and improve The ability and level of enterprise resource acquisition. At the Yunnan Jianfeng middle-level cadre meeting held on the afternoon of the 16th, Jiang Xiaomeng first fully affirmed Yunnan Jianfeng's highest output and best benefits since it was put into production in 2018, and expressed his gratitude to all cadres and employees of Yunnan Jianfeng for their hard work. After that, Jiang Xiaomeng made a detailed analysis of the cement industry and the regional market environment in Yunnan, and combined with the current production and operation situation of Yunnan Jianfeng, put forward the focus of the next step: 1. should fully attach importance to and mobilize the initiative and responsibility of employees at all levels to improve the overall execution of the team; 2. raw material mines are an important factor restricting the future development of cement enterprises, which should be paid full attention to and formulate clear strategies and methods, set out a timetable to obtain future production resources as much as possible; 3. continuously advocate and promote technological innovation, keep pace with the times, continuously improve production management, equipment management, production technology level, and maintain the competitive advantage of the industry; 4. further strengthen production
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page